▶주메뉴 바로가기
▶본문 바로가기
SAN DIEGO – Korea’s biotechnology industry has rapidly emerged as one of Asia's most promising innovation ecosystems, but industry experts say securing global capital and adopting more flexible business models remain critical challenges if the country hopes to position itself as a global biotech powerhouse. “Korea is already an innovation hub,” said Hwang Jurie, director of public and international affairs at the Korea Biotechnology Industry Organization, or KoreaBIO, during a panel discussion t
SAN DIEGO – Samsung Biologics will establish its first official European sales office in Amsterdam, as the leading Korean contract development and manufacturing organization, or CDMO, looks to continue expanding its global presence. “We are planning to open the European sales office in the third quarter of this year,” said John Rim, CEO of Samsung Biologics, in a press conference held on the sidelines of the BIO International Convention in San Diego on Tuesday. “Located at the center of Europe,
Korea Herald correspondent SAN DIEGO — SK Biopharmaceuticals has bet big on artificial intelligence and open innovation as the two core pillars that will drive the Korean drugmaker’s future growth. “It took us almost 30 years to launch Xcopri as we did everything from development to commercialization and sales, unlike other firms,” said Lee Dong-hoon, CEO of SK Biopharmaceuticals, in a press conference at the BIO International Convention in San Diego on Monday. The growing sales of Xcopri, which
SAN DIEGO — Korean biotechnology firms have advanced their partnerships with AstraZeneca, bolstering efforts toward open innovation and technological cooperation for eventual entrance into the global market. Under the name Project NOVA, the Korea Health Industry Development Institute on Monday held AstraZeneca partnering sessions for 13 Korean companies on the sidelines of the BIO International Convention taking place this week in San Diego. “We have a very good track record of doing excellent p
Korea Herald correspondent SAN DIEGO — Korea’s biotechnology sector faces a shrinking window of opportunity as China’s surge in new drug development accelerates on the global stage, an industry expert warned Tuesday. “The center of gravity in biotech is clearly shifting toward Asia,” said Lee Seung-gyu, vice chair at the Korea Biotechnology Industry Organization (KoreaBio), in a press conference at the BIO International Convention in San Diego. “The question is whether Korea can secure enough co
A flock of Korean biopharmaceutical and biotechnology companies are heading to San Diego this week with their eyes on expanding global partnerships and securing contracts at the BIO International Convention, one of the world’s largest exhibitions in the biotechnology industry. Samsung Biologics, which will take part in the annual event for the 14th consecutive year, said it will once again set up a large booth with a floor space of 140 square meters at the center stage. The Korean contract devel
LG Chem said Thursday it signed a joint research and license option agreement with UK-based biotechnology company LabGenius Therapeutics to develop next-generation multispecific antibody therapies for cancer using artificial intelligence. LabGenius has developed EVA, an AI-powered drug discovery platform that combines machine learning with automated high-throughput experimentation to design and optimize therapeutic antibodies. Under the agreement, LG Chem will provide an upfront payment and rese
ABL Bio said Wednesday that the US Food and Drug Administration granted Fast Track designation to Givastomig (ABL111), its gastric cancer treatment candidate being jointly developed with NovaBridge Biosciences. The FDA's Fast Track program is designed to speed up the development and review of drugs that treat serious conditions and address unmet medical needs. Givastomig is a bispecific antibody that targets Claudin 18.2, a protein commonly overexpressed in gastric and pancreatic cancers, and 4-
Matica Biotechnology, the US subsidiary of CHA Biotech, said Wednesday it had launched its Matica Open Access Platform, with biotechnology firm Cirsium Biosciences becoming its first customer. The platform is designed to give drug developers greater control over manufacturing and development processes, challenging the traditional contract development and manufacturing organization model that often relies on proprietary platforms and long-term customer lock-in. According to Matica, customers reta
SK Plasma said Monday it has begun construction of a plasma fractionation plant in Turkey, as the Korean biopharmaceutical company accelerates efforts to build a global manufacturing network. The facility, to be operated through a joint venture with the Turkish Red Crescent, will process up to 600,000 liters of plasma annually and produce key plasma-derived medicines including albumin, immunoglobulin and Factor VIII concentrate. The groundbreaking ceremony was held at the project site in Cubuk,
Chipotle bets on Korea for first bite of Asia
Samsung vs. LG battle for AI cooling heats up
Musinsa posts record earnings on offline, global expansion
One purchase every 0.9 second: Olive Young foreign sales top W1tr
Samsung, SK hynix tax payments surge 167% on chip boom
SK Chemicals eyes European can-coating market
Sept. 2, 2026
![[Bio USA] Korean biotech has innovation. Now it needs capital](https://wimg.heraldcorp.com/news/cms/2026/06/24/news-p.v1.20260624.3bd7fead1e9b42e68fbc0839609ac5a7_T1.jpg?type=h&h=240)
June 24, 2026![[Bio USA] Samsung Biologics to open first European sales office in Amsterdam](https://wimg.heraldcorp.com/news/cms/2026/06/24/news-p.v1.20260624.240691d27e0c4984878394f2225bd95d_T1.jpg?type=h&h=240)
June 24, 2026![[Bio USA] SK Biopharmaceuticals doubles down on AI, open innovation](https://wimg.heraldcorp.com/news/cms/2026/06/24/news-p.v1.20260624.af48f71831da490ca3ceca37f78551bd_T1.jpg?type=h&h=240)
June 24, 2026![[Bio USA] Korean biotechs bolster AstraZeneca partnership](https://wimg.heraldcorp.com/news/cms/2026/06/23/news-p.v1.20260623.78369bb8ff2d45cc848eea83d0c0d815_T1.jpg?type=h&h=240)
June 23, 2026![[Bio USA] Korea biotech under pressure from China's rapid rise](https://wimg.heraldcorp.com/news/cms/2026/06/23/news-p.v1.20260623.e850232b25f14ddda1089d6932f9b2ef_T1.jpg?type=h&h=240)
June 23, 2026
June 21, 2026
June 18, 2026
June 17, 2026
June 17, 2026
June 15, 2026
